Learn More
Invitrogen™ VPAC2 Polyclonal Antibody

Description
PA3-114 detects VPAC2 Receptor in human samples. PA3-114 has been successfully used in Western blot, immunocytochemistry and immunohistochemistry procedures. By Western blot, this antibody detects an ~50-65 kDa protein representing VPAC2 Receptor in human samples. In immunohistochemistry, VPAC2 receptor immunoreactivity is predominantly localized to neuroendocrine cells. PA3-114 immunogen is a synthetic peptide, conjugated to KLH, corresponding to the residues L(419) Q F H R G S R A Q S F L Q T E T S V I(438) of human VPAC2 receptor.
Specifications
Specifications
| Antigen | VPAC2 |
| Applications | Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry |
| Classification | Polyclonal |
| Concentration | Conc. Not Determined |
| Conjugate | Unconjugated |
| Formulation | Whole Serum with 0.05% sodium azide |
| Gene | Vipr2 |
| Gene Accession No. | P41587 |
| Gene Alias | C16DUPq36.3; DUP7q36.3; helodermin-preferring VIP receptor; PACAP type III receptor; Pacap type-3; PACAP3; PACAP-R3; PACAP-R-3; PACAPR-3; pituitary adenylate cyclase-activating polypeptide type III receptor; Pvr3; SCZD16; tcag7.970; vasoactive intestinal peptide receptor 2; vasoactive intestinal polypeptide receptor 2; vasopressive intestinal peptide receptor 2; VIP and PACAP receptor 2; VIP receptor subtype 2; Vip type-2 receptor; Vip2; Vip2 receptor; VIP2R; Vipr2; Vip-r2; VIP-R-2; VPAC2; VPAC2 receptor; VPAC2R; VPCAP2R |
| Gene Symbols | Vipr2 |
| Show More |
Safety and Handling
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.